Conatus Pharmaceuticals Inc. 4
4 · Conatus Pharmaceuticals Inc. · Filed Feb 1, 2017
Insider Transaction Report
Form 4
Hagerty David T
EVP, Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2017-01-26+100,625→ 100,625 totalExercise: $4.21Exp: 2027-01-25→ Common Stock (100,625 underlying)
Footnotes (1)
- [F1]The option was granted on January 26, 2017. 25% of the total number of shares of common stock subject to the option will vest on January 26, 2018, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.